Perfect Heartio herbal drink for heart and blood-fat health

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls generally healthy adults aged 18 and older to take the Perfect Heartio nutritional drink, a blend of traditional Chinese medicine herbal extracts, and return for scheduled follow-up visits. Participants will consume the drink according to the study plan while investigators monitor cardiovascular-related measures and markers of lipid metabolism. The protocol excludes people on anticoagulants, corticosteroids, frequent NSAID users, those taking high-dose vitamin A/E/beta-carotene supplements, pregnant or lactating women, and individuals with serious organ failure or active cancer. The trial is sponsored by The Perfect Series Sdn Bhd in collaboration with UCSI University and is conducted at UCSI University in Cheras, Kuala Lumpur.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* General healthy subjects during enrolment
* Age 18 and above
* Willing to comply with interventional plan and comes to do follow up
* Willing to gives consent

Exclusion Criteria:

* Use nonsteroidal anti-inflammatory drugs (NSAIDs) more than once a week during enrolment
* Use of anticoagulants or corticosteroids
* Use of individual supplements of vitamin A, E, or beta carotene more than once a week during enrolment
* Renal failure or dialysis, cirrhosis, other serious conditions that precluded participation
* No previous history of cancer (except nonmelanoma skin cancer)
* Pregnant or lactating woman

Where it's running

• UCSI University
  Cheras, Kuala Lumpur, Malaysia Recruiting

Study contacts

• Principal investigator: Chung Keat Tan, PhD — UCSI University
• Study coordinator: Chung Keat Tan, PhD
• Email: cktan@ucsiuniversity.edu.my
• Phone: 0175063305

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Abnormal menstrual bleeding in women on antithrombotic drugs after heart surgery

  This study looks at whether women on blood thinners after heart surgery have abnormal menstrual bleeding and what factors might put some at higher risk.

  Recruiting Shanghai Zhongshan Hospital · Shanghai, Shanghai Municipality · NCT07870941

• AI-powered ECG to help diagnose and predict outcomes in heart disease

  Researchers test an AI-enhanced ECG to help diagnose and predict outcomes for people with cardiovascular diseases.

  Recruiting Inha University Hospital · Incheon, Incheon · NCT07856472

• Colchicine for preventing cardiovascular disease in adults with type 2 diabetes

  A 24-week study will test whether low-dose colchicine can help protect blood vessels in adults with type 2 diabetes who have not yet developed artery disease, compared with a placebo.

  Recruiting Phase 2 Tan Tock Seng Hospital · Singapore, Singapore · NCT07837934

• Optimised Cardio-Renal Care for CKD and heart disease

  This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.

  Recruiting Odense University Hospital · Svendborg · NCT07835828

• Inhaled mosliciguat for pulmonary hypertension in interstitial lung disease (PH-ILD) patients

  This study tests inhaled mosliciguat versus placebo in people with PH-ILD to see if it helps with their condition.

  Recruiting at 3 sites Phase 3 Pulmovant, Inc. · Kissimmee, Florida and 2 other locations · NCT07816185

• One-stop photon-counting CT for patients after PCI

  This study tests a single CT exam using photon-counting technology to image the heart after stent placement in people who have had PCI.

  Recruiting Chinese PLA General Hospital · Beijing, Beijing Municipality · NCT07763340

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.